Literature DB >> 26530922

Hypoxia-Responsive Copolymer for siRNA Delivery.

Federico Perche1,2, Swati Biswas1,2, Niravkumar R Patel1,2, Vladimir P Torchilin3,4.   

Abstract

A wide variety of nanomedicine has been designed for cancer therapy. Herein, we describe the synthesis and evaluation of a hypoxia-responsive copolymer for siRNA delivery (Perche et al., Angew Chem Int Ed Engl 53:3362-3366, 2014). The synthesis is achieved using established coupling chemistry and accessible purification procedures. A polyelectrolyte-lipid conjugate (polyethyleneimine 1.8 kDa-dioleyl-phosphatidylinositol, PEI-PE) and polyethylene glycol 2000 (PEG) were assembled via the hypoxia-sensitive azobenzene (Azo) unit to obtain the PEG-Azo-PEI-DOPE copolymer. This copolymer can condense siRNA and shows hypoxia-induced cellular internalization and reporter gene downregulation in vitro and tumor accumulation in vivo after parenteral administration (Perche et al., Angew Chem Int Ed Engl 53:3362-3366, 2014). We also detail procedures to evaluate hypoxia-targeted polymers both in monolayer cultures, cancer cell spheroids and in tumor xenografts murine models.

Entities:  

Keywords:  Azobenzene; Stimuli-sensitive; Tumor hypoxia; Tumor targeting; siRNA delivery

Mesh:

Substances:

Year:  2016        PMID: 26530922     DOI: 10.1007/978-1-4939-3148-4_12

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  7 in total

Review 1.  Nanoparticles for Targeting Intratumoral Hypoxia: Exploiting a Potential Weakness of Glioblastoma.

Authors:  Mihaela Aldea; Ioan Alexandru Florian; Gabriel Kacso; Lucian Craciun; Sanda Boca; Olga Soritau; Ioan Stefan Florian
Journal:  Pharm Res       Date:  2016-05-26       Impact factor: 4.200

2.  Neutral Lipopolyplexes for In Vivo Delivery of Conventional and Replicative RNA Vaccine.

Authors:  Federico Perche; Rudy Clemençon; Kai Schulze; Thomas Ebensen; Carlos A Guzmán; Chantal Pichon
Journal:  Mol Ther Nucleic Acids       Date:  2019-07-30       Impact factor: 8.886

3.  Histone glycation: Linking metabolic perturbation with epigenetic misregulation in cancer.

Authors:  Xiayao Diao
Journal:  AIMS Genet       Date:  2019-06-04

Review 4.  Emerging nanobiotechnology for precise theranostics of hepatocellular carcinoma.

Authors:  Mengjiao Xu; Liu Yang; Yanjie Lin; Yao Lu; Xiaoyue Bi; Tingting Jiang; Wen Deng; Lu Zhang; Wei Yi; Yao Xie; Minghui Li
Journal:  J Nanobiotechnology       Date:  2022-09-29       Impact factor: 9.429

Review 5.  Recent Advances in Stimulus-Responsive Nanocarriers for Gene Therapy.

Authors:  Cheng Yu; Long Li; Pei Hu; Yan Yang; Wei Wei; Xin Deng; Lu Wang; Franklin R Tay; Jingzhi Ma
Journal:  Adv Sci (Weinh)       Date:  2021-05-16       Impact factor: 16.806

Review 6.  Stimuli-responsive nanocarriers for drug delivery, tumor imaging, therapy and theranostics.

Authors:  Peng Mi
Journal:  Theranostics       Date:  2020-03-15       Impact factor: 11.556

Review 7.  Alliance with EPR Effect: Combined Strategies to Improve the EPR Effect in the Tumor Microenvironment.

Authors:  Jooho Park; Yongwhan Choi; Hyeyoun Chang; Wooram Um; Ju Hee Ryu; Ick Chan Kwon
Journal:  Theranostics       Date:  2019-10-17       Impact factor: 11.556

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.